Literature DB >> 8987986

Calcium binding properties of synthetic gamma-carboxyglutamic acid-containing marine cone snail "sleeper" peptides, conantokin-G and conantokin-T.

M Prorok1, S E Warder, T Blandl, F J Castellino.   

Abstract

Total chemical synthesis of two Conus-derived peptides, conantokin-G (con-G), a 17-residue polypeptide containing five residues of gamma-carboxyglutamic acid (Gla), and conantokin-T (con-T), a 21-residue polypeptide possessing four residues of Gla, was accomplished. Calcium binding isotherms were obtained for each peptide, and these differed considerably from each other. The binding isotherm for con-G was complex and could only be fit to degenerate models involving multiple Ca2+ binding sites. The data for Ca2+ binding to con-T was uniquely fit to a simple one-site model. In the case of con-G, circular dichroism (CD) studies revealed a polypeptide without observable alpha-helicity in the absence of Ca2+ and a dramatic shift to a high degree of alpha-helix at saturating Ca2+ concentrations. In contrast, apo-con-T possessed significant alpha-helical structure, and saturation with Ca2+ produced a less substantial change in its alpha-helical content. Titrations with Ca2+ of the change in alpha-helical content of con-T produced a C50 value for Ca2+ that was essentially the same as its Kd from direct binding studies, demonstrating that occupancy of the single macroscopic binding site resulted in the conformational change. Similar titrations with con-G provided a C50 value in concert with the Kd for binding of Ca2+ to this peptide. Moreover, in agreement with these particular Ca(2+)-induced structural changes, gel filtration analyses demonstrated significantly reduced hydrodynamic volumes of both of these polypeptides after saturation of their apo forms with Ca2+, with con-G showing a more pronounced change than con-T. One-dimensional H-NMR spectra showed both line broadening and changes in chemical shifts of several peptide amide proton resonances after addition of Ca2+ to con-G, again suggestive of a large Ca(2+)-induced conformational change in this polypeptide. A derivative of con-G was synthesized with all amino acids present in the D-configuration (D-con-G). This variant peptide displayed Ca2+ binding isotherms nearly identical to those of con-G and underwent a Ca(2+)-induced conformational change very similar to that of con-G. Intracranial injections of con-G and con-T in young (< 2 weeks) and older (3-4 weeks) mice produced the expected "sleep-like" and hyperactive effects, respectively. The variant, D-con-G, was inactive in these assays. These studies demonstrate that synthetic con-G and con-T possess their expected bioactivities and undergo large and defined conformational alterations in the presence of Ca2+. We propose that binding of Ca2+ to these polypeptides contributes to their ability to adopt a defined conformation, and this divalent cation-dependent conformation is necessary for their neuroactivities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987986     DOI: 10.1021/bi9621122

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors.

Authors:  Rashna Balsara; Neill Li; Danielle Weber-Adrian; Louxiu Huang; Francis J Castellino
Journal:  Neuropharmacology       Date:  2012-01-27       Impact factor: 5.250

2.  Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.

Authors:  Konkallu Hanumae Gowd; Tiffany S Han; Vernon Twede; Joanna Gajewiak; Misty D Smith; Maren Watkins; Randall J Platt; Gabriela Toledo; H Steve White; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Biochemistry       Date:  2012-05-30       Impact factor: 3.162

3.  Non-strict strand orientation of the Ca2+-induced dimerization of a conantokin peptide variant with sequence-shifted gamma-carboxyglutamate residues.

Authors:  Qiuyun Dai; Cai Xiao; Mingxin Dong; Zhuguo Liu; Zhenyu Sheng; Francis J Castellino; Mary Prorok
Journal:  Peptides       Date:  2009-01-24       Impact factor: 3.750

4.  Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.

Authors:  John Cheriyan; Rashna D Balsara; Kasper B Hansen; Francis J Castellino
Journal:  Neurosci Lett       Date:  2016-02-23       Impact factor: 3.046

5.  Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities toward Ion Channels of N-Methyl-d-aspartate Receptors.

Authors:  Shailaja Kunda; Yue Yuan; Rashna D Balsara; Jaroslav Zajicek; Francis J Castellino
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

6.  Probing NMDA receptor GluN2A and GluN2B subunit expression and distribution in cortical neurons.

Authors:  Rashna D Balsara; Ashley N Ferreira; Deborah L Donahue; Francis J Castellino; Patrick L Sheets
Journal:  Neuropharmacology       Date:  2014-01-15       Impact factor: 5.250

7.  Gamma-carboxylation and fragmentation of osteocalcin in human serum defined by mass spectrometry.

Authors:  Douglas S Rehder; Caren M Gundberg; Sarah L Booth; Chad R Borges
Journal:  Mol Cell Proteomics       Date:  2015-04-08       Impact factor: 5.911

8.  Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.

Authors:  Z Sheng; M Prorok; F J Castellino
Journal:  Neuroscience       Date:  2010-08-03       Impact factor: 3.590

9.  The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.

Authors:  Zhenyu Sheng; Zhong Liang; James H Geiger; Mary Prorok; Francis J Castellino
Journal:  Neuropharmacology       Date:  2009-05-08       Impact factor: 5.250

10.  N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein.

Authors:  Zhenyu Sheng; Mary Prorok; Brigid E Brown; Francis J Castellino
Journal:  Neuropharmacology       Date:  2008-05-24       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.